Our Team

With  deep knowledge of the cannabis plant and the complex and regulated medicinal cannabis ecosystem, our team will draw upon years of experience and an extensive network of contacts to help us identify and evaluate promising opportunities for investment and for organic growth.


Sharon Segal - Non-Executive Chair

Sharon Segal has over 20 years' experience in investment markets having spent the early part of her investment career with Deutsche Bank as a sell side equities analyst and then with Aviva Investors as a UK Small-Mid Cap Fund Manager, responsible for c£1 billion in assets under management. Subsequently she led the Regulated Fund of Funds team at Fitzwilliam Asset Management and was the lead Fund Manager of the award-winning fund, Fitzwilliam Balanced Managed Fund and has also held an 'AA' rating from Citywire.

Currently, Sharon is Finance Director at Patty & Bun, a Burger Chain Restaurant Group. She has also previously worked at The ONE Group as Director of Finance, having joined the business in 2011, in order to open the UK/European office and head up the European expansion. The ONE Group is a global leader in the hospitality industry and the creator of the international restaurants brand STK. More recent roles include Finance Director for Safestay plc and The Allbright Group. Currently a NED at JW3, the first Jewish Community Centre and arts venue of its kind to exist in London.

Sharon holds a BA (Hons) in Economics from Manchester University, an MA in Demography from the Hebrew University in Jerusalem and is an MBA graduate from the London Business School.

Gavin Sathianathan - Investment Strategy Director

Gavin Sathianathan is a recognised advocate for the European cannabis industry. Gavin is the CEO of Alta Flora, a digital health and telemedicine platform focused on novel therapeutics including medical cannabis. Gavin is also co-founder and non-executive director of Oxford Cannabinoid Technologies (OCT), a bio-pharmaceutical business established in conjunction with the University of Oxford.

Gavin has been an advisor to the All Party Parliamentary Group on medical cannabis, regularly works with investors on the evolution of the cannabis market and has advised multiple FTSE 100 CPG companies. He was profiled in the Times of London as “Britain’s Cannabis Capitalist” and named as “marijuana magnate” by The Spectator. Gavin started his career at Bain & Company, spending four years in London before moving to Delhi as part of the founding team of Bain's Indian operation. Gavin then pursued a career in the digital media industry, initially in content creation at Endemol before joining Facebook in Europe as one of the early team to grow the business ahead of the IPO. He was also Managing Director at Tesco, focused on technology, data, and digital media.

Gavin has a degree in Chemical Engineering from Imperial College, London, and an MBA from Harvard Business School.

Toby Shillito - Acting Chief Executive Officer

Toby has been designing and operating licensed facilities to cultivate Medical Cannabis in Europe over the past 7 years, assessing the value of many technological innovations in this space. He is knowledgable about the business models that are likely to succeed in the post-prohibition era and keen to assist Cannabis companies to operate within their social and environmental responsibilities